vs
Aterian, Inc.(ATER)与礼来(RNA)财务数据对比。点击上方公司名可切换其他公司
Aterian, Inc.的季度营收约是礼来的1.2倍($15.1M vs $12.5M),Aterian, Inc.净利率更高(-52.5% vs -1398.3%,领先1345.8%),礼来同比增速更快(434.0% vs -38.5%),Aterian, Inc.自由现金流更多($-1.0M vs $-156.9M),过去两年礼来的营收复合增速更高(138.5% vs -13.5%)
Aterian, Inc.是一家技术驱动的消费品企业,依托人工智能与数据分析挖掘市场需求,开发、采购并销售家居、个护、健康、户外、宠物用品等多品类高性价比商品,主要通过全球主流电商平台销往北美、欧洲等核心市场。
礼来是总部位于美国印第安纳州印第安纳波利斯的跨国制药企业,在18个国家设有办事处,产品销往全球约125个国家。公司由美国内战时期联邦军退伍军人、药剂师伊莱·礼来于1876年创立,品牌名即取自创始人姓名。
ATER vs RNA — 直观对比
营收规模更大
ATER
是对方的1.2倍
$12.5M
营收增速更快
RNA
高出472.5%
-38.5%
净利率更高
ATER
高出1345.8%
-1398.3%
自由现金流更多
ATER
多$155.8M
$-156.9M
两年增速更快
RNA
近两年复合增速
-13.5%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $15.1M | $12.5M |
| 净利润 | $-7.9M | $-174.4M |
| 毛利率 | 56.1% | — |
| 营业利润率 | -51.1% | -1513.5% |
| 净利率 | -52.5% | -1398.3% |
| 营收同比 | -38.5% | 434.0% |
| 净利润同比 | -512.2% | -117.0% |
| 每股收益(稀释后) | — | $-1.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ATER
RNA
| Q4 25 | $15.1M | — | ||
| Q3 25 | $19.0M | $12.5M | ||
| Q2 25 | $19.5M | $3.8M | ||
| Q1 25 | $15.4M | $1.6M | ||
| Q4 24 | $24.6M | $3.0M | ||
| Q3 24 | $26.2M | $2.3M | ||
| Q2 24 | $28.0M | $2.0M | ||
| Q1 24 | $20.2M | $3.5M |
净利润
ATER
RNA
| Q4 25 | $-7.9M | — | ||
| Q3 25 | $-2.3M | $-174.4M | ||
| Q2 25 | $-4.9M | $-157.3M | ||
| Q1 25 | $-3.9M | $-115.8M | ||
| Q4 24 | $-1.3M | $-102.3M | ||
| Q3 24 | $-1.8M | $-80.4M | ||
| Q2 24 | $-3.6M | $-70.8M | ||
| Q1 24 | $-5.2M | $-68.9M |
毛利率
ATER
RNA
| Q4 25 | 56.1% | — | ||
| Q3 25 | 56.1% | — | ||
| Q2 25 | 54.3% | — | ||
| Q1 25 | 61.4% | — | ||
| Q4 24 | 63.4% | — | ||
| Q3 24 | 60.3% | — | ||
| Q2 24 | 60.4% | — | ||
| Q1 24 | 65.1% | — |
营业利润率
ATER
RNA
| Q4 25 | -51.1% | — | ||
| Q3 25 | -10.7% | -1513.5% | ||
| Q2 25 | -23.1% | -4448.7% | ||
| Q1 25 | -24.1% | -8360.9% | ||
| Q4 24 | -6.5% | -4069.6% | ||
| Q3 24 | -6.6% | -4200.9% | ||
| Q2 24 | -11.5% | -4040.4% | ||
| Q1 24 | -26.1% | -2178.6% |
净利率
ATER
RNA
| Q4 25 | -52.5% | — | ||
| Q3 25 | -12.0% | -1398.3% | ||
| Q2 25 | -25.0% | -4089.3% | ||
| Q1 25 | -25.4% | -7360.0% | ||
| Q4 24 | -5.3% | -3439.5% | ||
| Q3 24 | -6.8% | -3441.7% | ||
| Q2 24 | -13.0% | -3461.8% | ||
| Q1 24 | -25.5% | -1943.4% |
每股收益(稀释后)
ATER
RNA
| Q4 25 | — | — | ||
| Q3 25 | — | $-1.27 | ||
| Q2 25 | — | $-1.21 | ||
| Q1 25 | — | $-0.90 | ||
| Q4 24 | — | $-0.80 | ||
| Q3 24 | — | $-0.65 | ||
| Q2 24 | — | $-0.65 | ||
| Q1 24 | — | $-0.79 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $4.9M | $350.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $15.2M | $1.9B |
| 总资产 | $29.6M | $2.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
ATER
RNA
| Q4 25 | $4.9M | — | ||
| Q3 25 | $7.6M | $350.2M | ||
| Q2 25 | $10.5M | $243.9M | ||
| Q1 25 | $14.3M | $254.2M | ||
| Q4 24 | $18.0M | $219.9M | ||
| Q3 24 | $16.1M | $370.2M | ||
| Q2 24 | $20.3M | $575.8M | ||
| Q1 24 | $17.5M | $471.4M |
股东权益
ATER
RNA
| Q4 25 | $15.2M | — | ||
| Q3 25 | $22.6M | $1.9B | ||
| Q2 25 | $24.3M | $1.2B | ||
| Q1 25 | $27.0M | $1.3B | ||
| Q4 24 | $30.0M | $1.4B | ||
| Q3 24 | $30.6M | $1.5B | ||
| Q2 24 | $30.9M | $1.2B | ||
| Q1 24 | $33.0M | $830.9M |
总资产
ATER
RNA
| Q4 25 | $29.6M | — | ||
| Q3 25 | $40.1M | $2.1B | ||
| Q2 25 | $45.4M | $1.4B | ||
| Q1 25 | $49.8M | $1.5B | ||
| Q4 24 | $49.5M | $1.6B | ||
| Q3 24 | $52.1M | $1.6B | ||
| Q2 24 | $59.9M | $1.3B | ||
| Q1 24 | $55.7M | $951.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-1.0M | $-156.2M |
| 自由现金流经营现金流 - 资本支出 | $-1.0M | $-156.9M |
| 自由现金流率自由现金流/营收 | -6.9% | -1257.6% |
| 资本支出强度资本支出/营收 | 0.0% | 5.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-592.3M |
8季度趋势,按日历期对齐
经营现金流
ATER
RNA
| Q4 25 | $-1.0M | — | ||
| Q3 25 | $-1.6M | $-156.2M | ||
| Q2 25 | $-4.4M | $-199.7M | ||
| Q1 25 | $-3.9M | $-124.8M | ||
| Q4 24 | $-9.0K | $-99.9M | ||
| Q3 24 | $-722.0K | $-65.6M | ||
| Q2 24 | $2.9M | $-65.0M | ||
| Q1 24 | $-6.0K | $-70.4M |
自由现金流
ATER
RNA
| Q4 25 | $-1.0M | — | ||
| Q3 25 | $-1.6M | $-156.9M | ||
| Q2 25 | $-4.4M | $-203.0M | ||
| Q1 25 | — | $-128.6M | ||
| Q4 24 | — | $-103.8M | ||
| Q3 24 | — | $-67.3M | ||
| Q2 24 | $2.9M | $-65.5M | ||
| Q1 24 | $-42.0K | $-71.3M |
自由现金流率
ATER
RNA
| Q4 25 | -6.9% | — | ||
| Q3 25 | -8.4% | -1257.6% | ||
| Q2 25 | -22.7% | -5277.1% | ||
| Q1 25 | — | -8174.3% | ||
| Q4 24 | — | -3491.0% | ||
| Q3 24 | — | -2881.8% | ||
| Q2 24 | 10.3% | -3204.6% | ||
| Q1 24 | -0.2% | -2012.3% |
资本支出强度
ATER
RNA
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.2% | 5.7% | ||
| Q2 25 | 0.0% | 86.9% | ||
| Q1 25 | 0.0% | 238.6% | ||
| Q4 24 | 0.0% | 131.7% | ||
| Q3 24 | 0.0% | 72.9% | ||
| Q2 24 | 0.0% | 26.0% | ||
| Q1 24 | 0.2% | 25.8% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATER
| Sales Channel Directly To Consumer | $13.1M | 87% |
| Heating Cooling And Air Quality | $2.1M | 14% |
RNA
暂无分部数据